CMS Approves Medicare Add-on Payment for Aidoc CT Triage AI

The Centers for Medicare & Medicaid Services (CMS) has approved a New Technology Add-on Payment (NTAP) for Aidoc's CARE Multi-Triage CT Body software. This regulatory move establishes a dedicated reimbursement path for the AI tool's use in eligible inpatient settings.

The approved software flags suspected urgent findings on both contrast and non-contrast CT studies of the chest, abdomen, and pelvis. According to reports from AuntMinnie and Diagnostic Imaging, the reimbursement is specifically designated for inpatients covered by Medicare fee-for-service plans. The NTAP reimbursement is scheduled to become available starting October 1, 2026.

The Shift Toward Broad AI

Historically, AI in radiology has largely consisted of "point solutions"—tools designed to identify a single specific finding. Aidoc's CARE Multi-Triage CT Body represents a shift toward "Broad AI," utilizing a multi-triage system capable of identifying 11 different time-sensitive findings in a single pass.

CMS utilizes the NTAP mechanism to provide additional payments for new technologies that significantly improve patient care and are not reasonably reimbursed under existing payment systems. By applying this to a multi-purpose triage tool, the agency is addressing the financial gap for technologies that automate workflow prioritization.

Industry Implications

This decision marks a significant shift in the economic landscape for radiology AI. By providing a dedicated payment path, CMS is acknowledging the clinical value of automated triage in reducing the time-to-treatment for critical inpatient conditions. This may pave the way for broader hospital adoption of multi-purpose AI tools, as the financial risk for implementing such systems is mitigated by federal reimbursement.

Aidoc has stated that this approval represents a novel reimbursement decision for AI software built on a healthcare foundation model, though this specific classification remains a company claim.

Future Outlook

As the industry looks toward the October 2026 implementation date, the focus will shift to how other AI vendors leverage this precedent. The approval suggests that CMS is increasingly open to reimbursing software that manages systemic workflows rather than just isolated diagnostic tasks. Market observers will be watching to see if this leads to a broader category of NTAP approvals for foundation-model-based AI tools across other imaging modalities.